Buscar
Mostrando ítems 121-130 de 1468
Effects of palladacycle complex on hematopoietic progenitor cells proliferation in vivo and in vitro and its relation with the inhibitory properties of this compound on the angiotensin-I converting enzyme activity
(Marcel Dekker Inc, 2004-01-01)
In the present study, we introduce a new class of organometallic compound, the Biphosphinic Palladacycle Complex [Pd (C-2, N-S(-)(dmpa)(dppf)] Cl (BPC), as an angiotensin-I converting-enzyme inhibitor (ACEI) with hematological ...
Angiotensin I-converting enzyme gene polymorphism influences chronic hypertensive response in the rat Goldblatt model
(LIPPINCOTT WILLIAMS & WILKINS, 2002-03)
Background and objective In humans, the insertion/ deletion polymorphism in the anglotensin (Ang) I converting enzyme (ACE) gene significantly determines ACE activity. The deletion allele induces higher ACE levels and is ...
Impact of coronary intensive care unit in treatment of myocardial infarction
(2017-03-01)
Introduction: The mortality rate attributed to ST-segment elevation myocardial infarction (STEMI) has decreased in the world. However, this disease is still responsible for high costs for health systems. Several factors ...
Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system
(2014)
Chronic RAS (renin-angiotensin system) activation by both AngII (angiotensin II) and aldosterone leads to hypertension and perpetuates a cascade of pro-hypertrophic, pro-inflammatory, pro-thrombotic and atherogenic effects ...
Neutral endopeptidase and angiotensin I converting enzyme insertion/deletion gene polymorphism in humans
(2004)
Neutral endopeptidase (NEP) hydrolyses angiotensins (Ang) I and II and generates angiotensin-(1-7) [Ang-(17)]. In humans, the insertion/deletion (I/D) angiotensin- I converting enzyme ( ACE) gene polymorphism determined ...